Welcome to our dedicated page for MSP Recovery SEC filings (Ticker: MSPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The MSP Recovery, Inc. (MSPR) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, offering insight into its reimbursement recovery business, technology initiatives, capital structure, and listing status. MSP Recovery describes itself as a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, and its filings expand on how this model operates in practice.
Through annual reports on Form 10‑K and quarterly reports on Form 10‑Q, MSP Recovery provides detailed information on its portfolio of assigned healthcare claims, legal strategies under the Medicare Secondary Payer Act and other laws, technology platforms such as LifeWallet and LifeChain, and risk factors related to liquidity, litigation, and regulatory matters. These periodic reports also discuss non‑GAAP measures, impairment assessments of definite‑lived intangible assets, and management’s views on going‑concern considerations.
Current reports on Form 8‑K document material events affecting the company. Recent 8‑Ks describe strategic term sheets with investors such as Hazel Partners and Virage Capital Management, bridge funding and working‑capital facilities, debt‑to‑equity conversions, and amendments to agreements with YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement and related convertible promissory notes. Other 8‑Ks address reverse stock splits implemented to address Nasdaq’s minimum bid‑price rule, confidential settlements with insurers and pharmaceutical defendants, and the settlement of litigation with counterparties such as Cano Health.
Filings under Item 3.01 of Form 8‑K and related disclosures outline Nasdaq listing‑compliance issues, including deficiencies in minimum stockholders’ equity and bid‑price requirements, the company’s submission of a compliance plan, and the subsequent Nasdaq Hearings Panel decision to delist MSP Recovery’s common stock from the Nasdaq Capital Market. The company reports that it expects its common stock to trade on the OTC Markets OTCQB market under the ticker MSPR following suspension from Nasdaq, which is an important consideration for investors tracking trading venues.
Notifications of late filing on Form 12b‑25 (NT 10‑Q) provide context when MSP Recovery is unable to file a quarterly report by the prescribed deadline, such as delays related to a transition to a new independent registered public accounting firm. These notices explain the reasons for the delay and whether the company expects to file within the permitted extension period.
On this page, users can review MSP Recovery’s 10‑K and 10‑Q reports, 8‑K current reports, and other SEC submissions, while AI‑powered tools summarize key sections, highlight significant changes, and call out items such as liquidity discussions, debt and equity arrangements, reverse stock splits, and listing‑status disclosures. This helps readers quickly understand how MSP Recovery’s legal, technological, and financial developments are reflected in its official regulatory record.
MSP Recovery, Inc. reports that a jury in the Menendez Litigation returned a mixed verdict involving the company and its subsidiary. The jury rejected all fraud and misrepresentation theories and found in favor of the company and its CEO, John H. Ruiz, on those claims and on the deceptive and unfair practices claim. However, the jury found that subsidiary MSP Recovery, LLC breached an alleged oral contract and awarded the plaintiffs approximately $12.7 million in damages against the subsidiary, which holds all of the company’s assets.
The court has not yet entered a final judgment, and the defendants are seeking post-trial relief, including a directed verdict, motions to set aside the verdict, and a potential appeal, while also planning to pursue recovery of attorneys’ fees for the company and Mr. Ruiz under Florida law. The company states that the verdict has added uncertainty to its financial condition and prospects and may negatively affect its ability to raise capital or continue as a going concern, and it is continuing to evaluate the impact on its business, results of operations, and financial condition.
MSP Recovery, Inc. reported the results of a Special Meeting of Stockholders held on August 18, 2025. Stockholders representing 6,875,550 common shares, or approximately 74.74% of eligible shares as of the July 11, 2025 record date, participated virtually or by proxy.
Stockholders approved an amendment to the company’s charter to allow a reverse stock split of common stock at a ratio between 1-for-2 and 1-for-7, with the exact ratio to be chosen by the Board of Directors and any other ratios in that range to be abandoned. This proposal passed with 6,640,800 votes for, 231,939 against, and 2,811 abstentions.
They also approved, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of Class A common shares to Virage Recovery Master LP upon exercise of the VRM Warrants, with 5,082,916 votes for, 143,965 against, 4,810 abstentions, and 1,643,859 broker non-votes.
MSP Recovery, Inc. (MSPR) reports continued operational activity but clear liquidity and legal timing risks. The company identified recoverable claims using proprietary Algorithms and reported total recoveries of $1.4 million for the six months ended June 30, 2025 and gross recoveries of $18.1 million for 2024. Intangible assets related to a consolidated VIE were $1.2 billion at June 30, 2025 versus $1.4 billion at December 31, 2024. The company disclosed significant related-party interest expense (e.g., $92.9 million and $182.3 million reported in certain periods) and material related-party balances. Working capital funding included $2.1 million from Yorkville (with $0.36 million unfunded) and $6.8 million advanced under the Hazel Working Capital Credit Facility; however, no capacity remains under that facility as of the filing. Legal risk: an Eleventh Circuit ruling could reduce PVPRC by an estimated $10.8 billion if applied broadly, and the company is pursuing tolling and other legal strategies. The company also disclosed that it has not recognized certain TRA liabilities because realization was deemed not probable.
MSP Recovery, Inc. confirmed its Standby Equity Purchase Agreement (SEPA) with Yorkville remains active, under which it may sell up to $250.0 million of common stock subject to conditions. Yorkville agreed to provide convertible promissory note advances with aggregate principal of $16.5 million. The filing details five prior notes (combined principal $16.5 million) with net proceeds disclosed for each issuance and a sixth Convertible Note for $0.75 million whose net proceeds will be disbursed in two payments of $0.36 million on August 8 and August 15, 2025.
The Convertible Notes convert at the lower of a Fixed Price or 95% of the lowest daily VWAP during the five trading days before conversion, but not below a $0.50 floor, and conversions are limited to avoid Yorkville exceeding a 9.99% ownership cap. Yorkville may also require issuance of shares to offset outstanding note balances (a "Yorkville Advance"). The company disclosed its 2025 Annual Meeting results: ~6,226,781 shares (≈75.53%) present; three Class III directors were reelected and the ratification vote for Deloitte as auditor passed, while the company previously engaged Baker Tilly to serve as its independent auditor for the remainder of 2025 beginning in Q3.